A federal judge in Newark has signed off on a $3 million settlement of suits against the maker of anti-aging cream Hydroxatone over allegedly shoddy business practices.
U.S. District Judge Kevin McNulty approved the agreement on Nov. 22 despite a vehement challenge by an objector who maintains the litigation is worth tens of millions more.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
